医薬品有効成分(API)の世界市場規模及び予測:合成別(バイオ技術、合成)、メーカー種類別(キャプティブ、マーチャント)、種類別(一般、革新的)、用途別、動向分析 2014-2025

◆英語タイトル:Active Pharmaceutical Ingredients (API) Market Size And Forecast By Type of Synthesis (Biotech, Synthetic), By Type of Manufacturer (Captive, Merchant), By Type (Generic, Innovative), By Application And Trend Analysis, 2014-2025
◆発行会社/調査会社:Grand View Research
◆商品コード:GVIEW707013
◆発行日:2017年1月2日
◆調査対象地域:グローバル
◆産業分野:医療
◆ページ数:95
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Multi UserUSD7,950 ⇒換算¥874,500見積依頼/購入/質問フォーム
Global/corporate LicenseUSD9,950 ⇒換算¥1,094,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[医薬品有効成分(API)の世界市場規模及び予測:合成別(バイオ技術、合成)、メーカー種類別(キャプティブ、マーチャント)、種類別(一般、革新的)、用途別、動向分析 2014-2025]についてメールでお問い合わせはこちら
本調査レポートでは、医薬品有効成分(API)の世界市場について調査・分析し、医薬品有効成分(API)の世界市場動向、医薬品有効成分(API)の世界市場規模、市場予測、セグメント別医薬品有効成分(API)市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
*** レポート概要(サマリー)***

The global active pharmaceutical pngredients (API) market is expected to reach a value of USD 239.8 billion by 2025, based on a new report by Grand View Research, Inc. The rising prevalence of lifestyle-induced & age-related diseases and cancer is projected to drive the market over the forecast period. Advancements in recombinant molecular technologies and high capitalization for development of novel drugs are also estimated to boost growth.
Favorable government initiatives for increasing focus toward generic drugs is a key factor for market growth. Decrease in generic drug prices, higher acceptance in low income and decrease in reimbursement for branded drugs are the recent trends in the market affirming growth of generic drugs.

Further Key Findings from the Study Suggest:

Synthetic APIs was the largest segment by revenue share in 2015 owing to high demand.

Biotech APIs are estimated to grow lucratively over the forecast period with high R&D initiatives being undertaken for their development

Captive manufacturers, being the conventional option of API manufacturing, held the majority of the share.

On the other hand, the merchant manufacturers segment is expected to be fastest-growing due to growing outsourcing activities

Generic APIs will experience lucrative growth over the forecast period attributed to patent expirations of branded drugs

APIs are identified to have highest application in cardiovascular therapeutics. Increasing mortality caused by heart diseases and growing demand for fast-acting drugs are the major factors contributing to dominance

North America dominated in terms of revenue share in 2015 and Asia Pacific is expected to grow at a significant growth rate over the forecast period

Some of the major companies in the API market are AbbVie, Inc., Boehringer Ingelheim GmbH, Cipla, Inc., and Merck & Co., Inc.

*** レポート目次(コンテンツ)***

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s internal database
1.2 Research Methodology
1.3 Geographic scope & assumptions
1.4 Region-wise market calculation
1.4.1 Region-wise market: Base estimates
1.4.2 Global market: CAGR calculation
1.5 Region-based segment share calculation
1.6 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 API Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.1.1 Market Driver Analysis
3.1.1.1 Growing geriatric population base
3.1.1.2 Growing prevalence of target diseases such as hospital acquired infections, genetic, cardiovascular and neurological diseases
3.1.1.3 Increasing preference for targeted therapy approach in cancer treatment
3.1.1.4 Increasing preference for outsourcing APIs
3.1.2 Market restraint analysis
3.1.2.1 Large capital investments and production cost
3.1.3 Stringent safety and handling regulations regarding APIs
3.2 Penetration & growth prospect mapping
3.3 Active Pharmaceutical Ingredient – SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis – Porter’s
Chapter 4 API Market: Type of Synthesis Estimates & Trend Analysis
4.1 Active pharmaceutical ingredient market: Type of synthesis movement analysis
4.2 Biotech
4.2.1 Biotech market, 2014 – 2025 (USD Billion)
4.2.2 Monoclonal Antibodies
4.2.3 Monoclonal Antibodies market, 2014 – 2025 (USD Billion)
4.2.4 Recombinant proteins
4.2.5 Recombinant proteins market, 2014 – 2025 (USD Billion)
4.2.6 Vaccines
4.2.7 Vaccines market, 2014 – 2025 (USD Billion)
4.3 Synthetic
4.3.1 Synthetic market, 2014 – 2025 (USD Billion)
Chapter 5 API Market: Type of Manufacturer Estimates & Trend Analysis
5.1 Active pharmaceutical ingredient market: Type of Manufacturer movement analysis
5.2 Captive APIs
5.2.1 Captive APIs market, 2014 – 2025 (USD Billion)
5.3 Merchant APIs
5.3.1 Merchant APIs market, 2014 – 2025 (USD Billion)
Chapter 6 API Market: Type Estimates & Trend Analysis
6.1 Active pharmaceutical ingredient market: Type movement analysis
6.2 Generic APIs
6.2.1 Generic APIs market, 2014 – 2025 (USD Billion)
6.3 Innovative APIs
6.3.1 Innovative APIs market, 2014 – 2025 (USD Billion)
Chapter 7 API Market: Application Estimates & Trend Analysis
7.1 Active pharmaceutical ingredient market: Application movement analysis
7.2 Cardiovascular Disease
7.2.1 Cardiovascular Disease market, 2014 – 2025 (USD Billion)
7.3 Oncology
7.3.1 Oncology market, 2014 – 2025 (USD Billion)
7.4 CNS and Neurological Disorders
7.4.1 CNS and Neurological Disorders market, 2014 – 2025 (USD Billion)
7.5 Orthopedic Disorders
7.5.1 Orthopedic Disorders market, 2014 – 2025 (USD Billion)
7.6 Endocrinology
7.6.1 Endocrinology market, 2014 – 2025 (USD Billion)
7.7 Pulmonology
7.7.1 Pulmonology market, 2014 – 2025 (USD Billion)
7.8 Gastrointestinal Disorders
7.8.1 Gastrointestinal Disorders market, 2014 – 2025 (USD Billion)
7.9 Nephrology
7.9.1 Nephrology market, 2014 – 2025 (USD Billion)
7.10 Ophthalmology
7.10.1 Ophthalmology market, 2014 – 2025 (USD Billion)
7.10.2 Others market, 2014 – 2025 (USD Billion)
Chapter 8 API Market: Regional Estimates & Trend Analysis
8.1 Active pharmaceutical ingredient market share, by region, 2015 & 2025
8.2 North America
8.2.1 North America active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.2.2 U.S
8.2.2.1 U.S active pharmaceutical Ingredient market, 2014 – 2025 (USD Billion)
8.2.3 Canada
8.2.3.1 Canada active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.3 Europe
8.3.1 Europe active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.3.2 UK
8.3.2.1 UK active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.3.3 Germany
8.3.3.1 Germany active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.4 Asia Pacific
8.4.1 Asia Pacific active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.4.2 Japan
8.4.2.1 Japan active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.4.3 China
8.4.3.1 China active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.4.4 India
8.4.4.1 India active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.5 Latin America
8.5.1 Latin America active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.5.2 Brazil
8.5.2.1 Brazil active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.5.3 Mexico
8.5.3.1 Mexico active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.6 MEA
8.6.1 MEA active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.6.2 South Africa
8.6.2.1 South Africa active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
Chapter 9 Competitive Landscape
9.1 Strategy Framework
9.2 Market Participation Categorization
9.3 Company Profiles
9.3.1 AbbVie, Inc.
9.3.1.1 Company overview
9.3.1.2 Financial performance
9.3.1.3 Product benchmarking
9.3.1.4 Strategic initiatives
9.3.2 Boehringer Ingelheim GmbH
9.3.2.1 Company overview
9.3.2.2 Financial performance
9.3.2.3 Product benchmarking
9.3.2.4 Strategic initiatives
9.3.3 Bristol-Myers Squibb Company
9.3.3.1 Company overview
9.3.3.2 Financial performance
9.3.3.3 Product benchmarking
9.3.3.4 Strategic initiatives
9.3.4 Cipla, Inc.
9.3.4.1 Company overview
9.3.4.2 Financial performance
9.3.4.3 Product benchmarking
9.3.4.4 Strategic initiatives
9.3.5 Merck& Co., Inc.
9.3.5.1 Company overview
9.3.5.2 Financial performance
9.3.5.3 Product benchmarking
9.3.5.4 Strategic initiatives
9.3.6 Albemarle Corporation
9.3.6.1 Company overview
9.3.6.2 Financial overview
9.3.6.3 Product benchmarking
9.3.6.4 Strategic initiatives
9.3.7 Aurobindo Pharma
9.3.7.1 Company overview
9.3.7.2 Financial overview
9.3.7.3 Product benchmarking
9.3.7.4 Strategic initiatives
9.3.8 Mylan N.V.
9.3.8.1 Company overview
9.3.8.2 Financial overview
9.3.8.3 Product benchmarking
9.3.8.4 Strategic initiatives
9.3.9 Teva Active Pharmaceuticals Industries Ltd.
9.3.9.1 Company overview
9.3.9.2 Financial overview
9.3.9.3 Product benchmarking
9.3.9.4 Strategic initiatives
9.3.10 Sun Pharmaceutical Industries, Ltd.
9.3.10.1 Company overview
9.3.10.2 Financial overview
9.3.10.3 Product benchmarking
9.3.10.4 Strategic initiatives
9.3.11 Dr. Reddy’s Laboratories Ltd
9.3.11.1 Company overview
9.3.11.2 Financial overview
9.3.11.3 Product benchmarking
9.3.11.4 Strategic initiatives

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Value chain based sizing & forecasting
FIG. 4 QFD modeling for market share assessment
FIG. 5 Market summary
FIG. 6 Market trends &outlook
FIG. 7 Market segmentation & scope
FIG. 8 Market driver relevance analysis (Current & future impact)
FIG. 9 Global percentage of population, by age group, 2050 and 2000
FIG. 10 Market restraint relevance analysis (Current & future impact)
FIG. 11 Penetration & growth prospect mapping
FIG. 12 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 13 Porter’s Five Forces Analysis
FIG. 14 Active pharmaceutical ingredient market type of synthesis outlook key takeaways
FIG. 15 Active pharmaceutical ingredient market: Type movement analysis
FIG. 16 Global biotech market, 2014 - 2025 (USD Billion)
FIG. 17 Global monoclonal Antibodies market, 2014 - 2025 (USD Billion)
FIG. 18 Global recombinant proteins market, 2014 - 2025 (USD Billion)
FIG. 19 Global vaccines market, 2014 - 2025 (USD Billion)
FIG. 20 Global synthetic market, 2014 - 2025 (USD Billion)
FIG. 21 Active pharmaceutical ingredient market type of manufacturer outlook key takeaways
FIG. 22 Active pharmaceutical ingredient market: Type of Manufacturer movement analysis
FIG. 23 Global Captive APIs market, 2014 - 2025 (USD Billion)
FIG. 24 Global merchant APIs market, 2014 - 2025 (USD Billion)
FIG. 25 Active pharmaceutical ingredient market type outlook key takeaways
FIG. 26 Active pharmaceutical ingredient market: Type movement analysis
FIG. 27 Global generic APIs market, 2014 - 2025 (USD Billion)
FIG. 28 Global innovative APIs market, 2014 - 2025 (USD Billion)
FIG. 29 Active pharmaceutical ingredient market application outlook key takeaways
FIG. 30 Active pharmaceutical ingredient market: Application movement analysis
FIG. 31 Global cardiovascular Disease market, 2014 - 2025 (USD Billion)
FIG. 32 Global oncology market, 2014 - 2025 (USD Billion)
FIG. 33 Global CNS and neurological disorders market, 2014 - 2025 (USD Billion)
FIG. 34 Global orthopedic disorders market, 2014 - 2025 (USD Billion)
FIG. 35 Global endocrinology market, 2014 - 2025 (USD Billion)
FIG. 36 Global pulmonology market, 2014 - 2025 (USD Billion)
FIG. 37 Global gastrointestinal disorders market, 2014 - 2025 (USD Billion)
FIG. 38 Global nephrology market, 2014 - 2025 (USD Billion)
FIG. 39 Global ophthalmology market, 2014 - 2025 (USD Billion)
FIG. 40 Global ophthalmology market, 2014 - 2025 (USD Billion)
FIG. 41 Regional market place: Key takeaways
FIG. 42 Regional outlook, 2015 & 2025
FIG. 43 North America active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
FIG. 44 U.S. active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
FIG. 45 Canada active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
FIG. 46 Europe active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
FIG. 47 UK active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
FIG. 48 Germany active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
FIG. 49 Asia Pacific active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
FIG. 50 Japan active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
FIG. 51 China active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
FIG. 52 India active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
FIG. 53 Latin America active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
FIG. 54 Brazil active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
FIG. 55 Mexico active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
FIG. 56 MEA active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
FIG. 57 South Africa active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
FIG. 58 Strategy framework
FIG. 59 Participant categorization

List of Tables

TABLE 1 Country share estimation
TABLE 2 North America active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
TABLE 3 North America biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 4 North America active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
TABLE 5 North America active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 6 North America active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 7 U.S. active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
TABLE 8 U.S. biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 9 U.S. active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
TABLE 10 U.S. active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 11 U.S. active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 12 Canada active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
TABLE 13 Canada biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 14 Canada active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
TABLE 15 Canada active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 16 Canada active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 17 Europe active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
TABLE 18 Europe biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 19 Europe active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
TABLE 20 Europe active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 21 Europe active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 22 UK active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
TABLE 23 UK biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 24 UK active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
TABLE 25 UK active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 26 UK active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 27 Germany active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
TABLE 28 Germany biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 29 Germany active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
TABLE 30 Germany active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 31 Germany active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 32 Asia Pacific active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
TABLE 33 Asia Pacific biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 34 Asia Pacific active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
TABLE 35 Asia Pacific active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 36 Asia Pacific active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 37 Japan active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
TABLE 38 Japan biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 39 Japan active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
TABLE 40 Japan active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 41 Japan active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 42 China active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
TABLE 43 China biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 44 China active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
TABLE 45 China active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 46 China active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 47 India active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
TABLE 48 India biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 49 India active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
TABLE 50 India active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 51 India active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 52 Latin America active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
TABLE 53 Latin America biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 54 Latin America active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
TABLE 55 Latin America active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 56 Latin America active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 57 Brazil active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
TABLE 58 Brazil biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 59 Brazil active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
TABLE 60 Brazil active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 61 Brazil active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 62 Mexico active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
TABLE 63 Mexico biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 64 Mexico active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
TABLE 65 Mexico active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 66 Mexico active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 67 MEA active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
TABLE 68 MEA biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 69 MEA active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
TABLE 70 MEA active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 71 MEA active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 72 South Africa active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
TABLE 73 South Africa biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 74 South Africa active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
TABLE 75 South Africa active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 76 South Africa active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GVIEW707013 )"医薬品有効成分(API)の世界市場規模及び予測:合成別(バイオ技術、合成)、メーカー種類別(キャプティブ、マーチャント)、種類別(一般、革新的)、用途別、動向分析 2014-2025" (英文:Active Pharmaceutical Ingredients (API) Market Size And Forecast By Type of Synthesis (Biotech, Synthetic), By Type of Manufacturer (Captive, Merchant), By Type (Generic, Innovative), By Application And Trend Analysis, 2014-2025 )はGrand View Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。